Does Ardelyx (NASDAQ:ARDX) Have A Healthy Balance Sheet?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of permanent loss is the risk I worry about... and every practical investor I know worries about. So it seems the smart money knows that debt - which is usually involved in bankruptcies - is a very important factor, when you assess how risky a company is. We can see that Ardelyx, Inc. (NASDAQ:ARDX) does use debt in its business. But is this debt a concern to shareholders?

Advertisement

When Is Debt A Problem?

Debt and other liabilities become risky for a business when it cannot easily fulfill those obligations, either with free cash flow or by raising capital at an attractive price. If things get really bad, the lenders can take control of the business. While that is not too common, we often do see indebted companies permanently diluting shareholders because lenders force them to raise capital at a distressed price. Having said that, the most common situation is where a company manages its debt reasonably well - and to its own advantage. When we examine debt levels, we first consider both cash and debt levels, together.

Check out our latest analysis for Ardelyx

What Is Ardelyx's Debt?

The chart below, which you can click on for greater detail, shows that Ardelyx had US$50.2m in debt in March 2020; about the same as the year before. But on the other hand it also has US$223.2m in cash, leading to a US$173.0m net cash position.

NasdaqGM:ARDX Historical Debt July 5th 2020
NasdaqGM:ARDX Historical Debt July 5th 2020

A Look At Ardelyx's Liabilities

We can see from the most recent balance sheet that Ardelyx had liabilities of US$23.4m falling due within a year, and liabilities of US$44.1m due beyond that. Offsetting these obligations, it had cash of US$223.2m as well as receivables valued at US$750.0k due within 12 months. So it can boast US$156.4m more liquid assets than total liabilities.

It's good to see that Ardelyx has plenty of liquidity on its balance sheet, suggesting conservative management of liabilities. Due to its strong net asset position, it is not likely to face issues with its lenders. Simply put, the fact that Ardelyx has more cash than debt is arguably a good indication that it can manage its debt safely. The balance sheet is clearly the area to focus on when you are analysing debt. But ultimately the future profitability of the business will decide if Ardelyx can strengthen its balance sheet over time. So if you're focused on the future you can check out this free report showing analyst profit forecasts.

While it hasn't made a profit, at least Ardelyx booked its first revenue as a publicly listed company, in the last twelve months.

So How Risky Is Ardelyx?

We have no doubt that loss making companies are, in general, riskier than profitable ones. And the fact is that over the last twelve months Ardelyx lost money at the earnings before interest and tax (EBIT) line. Indeed, in that time it burnt through US$85m of cash and made a loss of US$91m. But the saving grace is the US$173.0m on the balance sheet. That kitty means the company can keep spending for growth for at least two years, at current rates. The good news for shareholders is that Ardelyx has dazzling revenue growth, so there's a very good chance it can boost its free cash flow in the years to come. High growth pre-profit companies may well be risky, but they can also offer great rewards. There's no doubt that we learn most about debt from the balance sheet. However, not all investment risk resides within the balance sheet - far from it. Case in point: We've spotted 1 warning sign for Ardelyx you should be aware of.

At the end of the day, it's often better to focus on companies that are free from net debt. You can access our special list of such companies (all with a track record of profit growth). It's free.

When trading Ardelyx or any other investment, use the platform considered by many to be the Professional's Gateway to the Worlds Market, Interactive Brokers. You get the lowest-cost* trading on stocks, options, futures, forex, bonds and funds worldwide from a single integrated account.Promoted


New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
*Interactive Brokers Rated Lowest Cost Broker by StockBrokers.com Annual Online Review 2020


Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com.

About NasdaqGM:ARDX

Ardelyx

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.

Very undervalued with exceptional growth potential.

Advertisement

Weekly Picks

JO
Jolt_Communications
ZENA logo
Jolt_Communications on ZenaTech ·

ZenaTech: A big bet on the rise of AI drones and drones-as-a-service

Fair Value:US$6.8569.9% undervalued
27 users have followed this narrative
0 users have commented on this narrative
4 users have liked this narrative
TR
tripledub
INTU logo
tripledub on Intuit ·

A Wonderful Business at a Not-So-Wonderful Price

Fair Value:US$50016.7% undervalued
20 users have followed this narrative
0 users have commented on this narrative
18 users have liked this narrative
FA
A1AKK logo
FA_Trader on A1 A.K. Koh Group Berhad ·

A1 A.K. Koh Group Berhad: A simple local food story that could ride on Visit Malaysia 2026

Fair Value:RM 0.3343.9% undervalued
7 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
KA
AII logo
kaladorm on American Integrity Insurance Group ·

Priced for worse weather, but undervalued even for a high hurricane season

Fair Value:US$37.1949.9% undervalued
10 users have followed this narrative
0 users have commented on this narrative
3 users have liked this narrative

Updated Narratives

RI
richw
LEO logo
richw on BNY Mellon Strategic Municipals ·

LEO shares may increase in value as a result of being a target of action by Saba Capital Management

Fair Value:US$6.68.0% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
AN
andre_santos
V logo
andre_santos on Visa ·

Visa - A Fundamental and Historical Valuation

Fair Value:US$387.0723.7% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
AG
Agricola
CAML logo
Agricola on Central Asia Metals ·

A Case for Central Asia Metals to reach £15 by 2031 in a commodities bull market.

Fair Value:UK£1589.5% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

YA
SOFI logo
Yang_ on SoFi Technologies ·

SoFi Technologies: The Apex Aggregator and the Infrastructure of the Modern Financial System

Fair Value:US$22.9833.7% undervalued
49 users have followed this narrative
0 users have commented on this narrative
36 users have liked this narrative
PD
VRT logo
pdixit1 on Vertiv Holdings Co ·

The Infrastructure AI Cannot Be Built Without

Fair Value:US$408.6438.6% undervalued
40 users have followed this narrative
3 users have commented on this narrative
18 users have liked this narrative
ZA
PME logo
ZayaanS on Pro Medicus ·

Pro Medicus: The Market Is Confusing a Lumpy Quarter With a Broken Business

Fair Value:AU$196.7840.2% undervalued
33 users have followed this narrative
7 users have commented on this narrative
21 users have liked this narrative